Description

Temozolomide offered works as oral chemotherapy drug.

Specifications:
As alkylating agent it finds use as treatment of some brain cancers
Also used as second-line treatment for astrocytoma and first-line treatment for glioblastoma multiforme
Having Molar mass of 194.151 g/mol and CAS ID of 85622-93-1
As chemotherapy drug it finds use to treat certain types of brain tumours called glioblastoma multiforme/anaplastic astrocytoma
It is used as treatment on its own for glioblastoma multiforme or anaplastic astrocytoma that has reoccured or where previous treatment did not work
Medication works by stopping cancer cells from making new DNA